Hybridoma tumor cell lines and their monoclonal antibodies to theumatin
CA 1297819 C · Owner: International Genetic Engineering, Inc. · Inventors: Ghosh-Dastidar, Pradip
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
HYBRIDOMA TUMOR CELL LINES AND, THEIR MONOCLONAL ANTIBODIES TO THAUMATIN" ABSTRACT, Disclosed are murine-derived hybridoma tumor cell lines and monoclonal anti-thaumatin antibody substances produced by these cell lines. The monoclonal antibody substances may be used alone or in combination in immunological procedures for isolation of thaumatin and for quantitative detection of thaumatin in fluid samples.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Granted March 24, 1992. A Canadian patent filed before October 1, 1989 lasted 17 years from grant, so its term ended March 24, 2009.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.